Antifibrotic drugs in connective tissue disease-related interstitial lung disease (CTD-ILD): from mechanistic insights to therapeutic applications

Fibrosing interstitial lung disease (ILD) is one of the most important causes of morbidity and mortality in patients with connective tissue diseases (CTDs), which include systemic sclerosis, rheumatoid arthritis, Sjögren’s syndrome, idiopathic inflammatory myositis and systemic lupus erythematosus....

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Drugs Context
Päätekijät: Erre, Gian Luca, Sebastiani, Marco, Manfredi, Andreina, Gerratana, Elisabetta, Atzeni, Fabiola, Passiu, Giuseppe, Mangoni, Arduino A
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioExcel Publishing Ltd 2021
Aiheet:
Review
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7813437/
https://ncbi.nlm.nih.gov/pubmed/33505482
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7573/dic.2020-8-6
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia